Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests

Recent studies indicate that the incidence of thromboembolic events is increasing as a secondary complication in children with serious underlying diseases. The mechanism to eliminate these thrombi via the thrombolytic system in children is unknown. The baseline fibrinolytic system is age dependent, with significant variation between children and adults. Adult studies would suggest that the fibrinolytic response to venous occlusion has more clinical relevance than the baseline fibrinolytic system. The aim of this study was to determine whether the fibrinolytic response to venous occlusion stress testing in healthy adolescents differs from the response in healthy adults. Healthy adolescents (13-18 y) from a school population and normal adults were recruited. Pre-and postvenous occlusion blood samples were collected using standard techniques. Plasma tissue plasminogen activator, plasminogen activator inhibitor-1, plasminogen, α2-antiplasmin, α2-macroglubulin, D-dimers, euglobulin lysis time, and fibrinogen were measured on each sample. Adolescents had significantly decreased tissue plasminogen activator antigen levels and increased plasminogen activator inhibitor-1 activity levels after venous occlusion, resulting in significantly prolonged euglobulin lysis times. The results of our study confirm developmental differences in the fibrinolytic response to venous occlusion stress testing. The age-related differences in fibrinolytic response to venous occlusion of younger children and the significance of these differences on the pathophysiology of thromboembolic events in children require further studies.

[1]  S. Thorsen,et al.  A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. , 2009, Scandinavian journal of haematology.

[2]  R. Freedom,et al.  Enhanced Thrombin Regulation during Warfarin Therapy in Children Compared to Adults , 1998, Thrombosis and Haemostasis.

[3]  P. Monagle,et al.  Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups , 1998, Thrombosis and Haemostasis.

[4]  G. Lowe,et al.  Prediction of Postoperative Deep-Vein Thrombosis , 1997, Thrombosis and Haemostasis.

[5]  J. Paramo,et al.  Evaluation of the fibrinolytic system in full-term neonates , 1995, International journal of clinical & laboratory research.

[6]  F. Ofosu,et al.  α2-Macroglobulin Remains as Important as Antithrombin III for Thrombin Regulation in Cord Plasma in the Presence of Endothelial Cell Surfaces , 1995, Pediatric Research.

[7]  G. Pohl,et al.  Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA. , 1995, Thrombosis research.

[8]  M. Bernstein,et al.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE , 1994 .

[9]  F. Ofosu,et al.  Maturation of the hemostatic system during childhood. , 1992, Blood.

[10]  Boscoe M. Paes,et al.  Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration , 1992, Thrombosis and Haemostasis.

[11]  D. Keber,et al.  Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. , 1991, Thrombosis research.

[12]  H. Büller,et al.  Deep Vein Thrombosis and Fibrinolysis , 1991, Thrombosis and Haemostasis.

[13]  H. Niwano,et al.  Plasmin generation and fibrin(ogen)olysis following desmopressin infusion , 1991, American journal of hematology.

[14]  A. Jaffe,et al.  Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. , 1990, Circulation.

[15]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[16]  T. Wun,et al.  Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. , 1987, Blood.

[17]  T. Kooistra,et al.  Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells , 1987, Thrombosis and Haemostasis.

[18]  P. Philips,et al.  Indicators of depressed fibrinolytic activity in pre‐operative prediction of deep venous thrombosis , 1987, The British journal of surgery.

[19]  M. Jørgensen,et al.  Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis , 1987, British journal of haematology.

[20]  C. Forbes,et al.  Association Between Postoperative Hyper-Response in t-PA Inhibition and Deep Vein Thrombosis , 1986, Thrombosis and Haemostasis.

[21]  I. Nilsson Two different mechanisms in patients with venous thrombosis and defective fibrinolysis , 1985, British medical journal.

[22]  Assist. Prof. D Keber On the Use of Different Correction Factors for Hemoconcentration , 1983, Thrombosis and Haemostasis.

[23]  M. Hoylaerts,et al.  Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.

[24]  D. Collen On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[25]  A. Smokovitis Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. , 1978, Haemostasis.

[26]  R. Santler,et al.  [Fibrinolytic activity of the vein wall]. , 1977, Phlebologie.

[27]  C. Ruckley,et al.  Plasma fibrinolysis and postoperative deep vein thrombosis , 1976, The British journal of surgery.

[28]  M. Buckell THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY , 1958, Journal of clinical pathology.

[29]  J. Freyssinet,et al.  Assessment of the Fibrinolytic System , 1993 .

[30]  M. Andrew,et al.  Anticoagulation and thrombolysis in children. , 1992, Texas Heart Institute journal.

[31]  F. Ofosu,et al.  An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. , 1992, The Journal of clinical investigation.

[32]  D. Collen,et al.  Basic and clinical aspects of fibrinolysis and thrombolysis. , 1991, Blood.